Science & Technology

Therapeutic
Indications

Closeup of brain MRI scan result

Solution for Radiation Induced Tissue Damage

Development of drugs to selectively reduce radiotherapy-induced normal tissue damage may improve post-therapy quality of life and save lives.

nuclear_explosion_chrysbio

Solution for Nuclear Radiation Exposure

A single TP508 injection 24 hours after a lethal dose of whole body radiation significantly increases survival and reduces delayed effects of radiation.

Science &
Technology

Screen Shot 2019-12-12 at 2.46.16 PM

TP508 Peptide Technology -

The TP508 thrombin peptide is released locally following vascular injury to initiate cellular regenerative processes that lead to revascularization, stem cell activation, and tissue repair.

flow of red blood cells into the blood vessel, 3D illustration

Regenerative Medicine -

Chrysalis BioTherapeutics is developing a “next generation” therapeutic approach that harnesses the body’s natural regenerative signals to protect and activate endogenous progenitor stem cells.